Shannon Ball
About Shannon Ball
Shannon Ball is a Research Scientist and Epidemiologist currently working at EcoHealth Alliance in New York. With a background in public health and extensive experience in infectious disease research, she has contributed to various initiatives aimed at disease prevention and control.
Work at EcoHealth Alliance
Shannon Ball has been employed at EcoHealth Alliance since 2021, serving as a Research Scientist and Epidemiologist. In this role, she contributes to research on infectious diseases, particularly focusing on zoonotic diseases and their implications for public health. Her work involves collaborative research projects with international partners aimed at addressing global health challenges.
Education and Expertise
Shannon Ball holds a Master of Public Health (MPH) degree in Epidemiology and Biostatistics from Tufts University School of Medicine, which she completed from 2016 to 2017. She also earned a Bachelor of Arts (BA) in Public Health and International Relations from Tufts University from 2012 to 2015. Additionally, she participated in a Study Abroad program at Universidad de Sevilla in 2014, focusing on Advanced Liberal Arts.
Background
Shannon Ball has a diverse background in public health and epidemiology. She began her career with the U.S. Department of State as a Public Affairs Communications Assistant in 2013. She then gained experience in various roles, including as a Research Assistant at Boston Children's Hospital and as an Epidemiologist at the Maryland Department of Health, where she worked on HIV prevention and emerging infections.
Achievements
Throughout her career, Shannon Ball has participated in significant public health initiatives, including HIV program evaluation efforts aimed at enhancing disease prevention strategies. Her experience includes working as a Graduate Environmental Health Intern at the Centers for Disease Control and Prevention and holding multiple epidemiologist positions at the Maryland Department of Health, where she focused on HIV prevention and emerging infections.